ID NUP43_HUMAN Reviewed; 380 AA. AC Q8NFH3; B4E2F0; Q9H8S0; DT 27-JAN-2003, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2002, sequence version 1. DT 27-MAR-2024, entry version 181. DE RecName: Full=Nucleoporin Nup43; DE AltName: Full=Nup107-160 subcomplex subunit Nup43; DE AltName: Full=p42; GN Name=NUP43; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION. RX PubMed=12196509; DOI=10.1083/jcb.200206106; RA Cronshaw J.M., Krutchinsky A.N., Zhang W., Chait B.T., Matunis M.J.; RT "Proteomic analysis of the mammalian nuclear pore complex."; RL J. Cell Biol. 158:915-927(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE RP [LARGE SCALE MRNA] OF 247-380 (ISOFORM 1). RC TISSUE=Ovarian carcinoma, and Trachea; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., RA Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION IN THE NUP107-160 COMPLEX, AND SUBCELLULAR LOCATION. RX PubMed=15146057; DOI=10.1091/mbc.e03-12-0878; RA Loieodice I., Alves A., Rabut G., Van Overbeek M., Ellenberg J., RA Sibarita J.-B., Doye V.; RT "The entire Nup107-160 complex, including three new members, is targeted as RT one entity to kinetochores in mitosis."; RL Mol. Biol. Cell 15:3333-3344(2004). RN [6] RP FUNCTION OF THE NUP107-160 COMPLEX. RX PubMed=17363900; DOI=10.1038/sj.emboj.7601642; RA Zuccolo M., Alves A., Galy V., Bolhy S., Formstecher E., Racine V., RA Sibarita J.-B., Fukagawa T., Shiekhattar R., Yen T., Doye V.; RT "The human Nup107-160 nuclear pore subcomplex contributes to proper RT kinetochore functions."; RL EMBO J. 26:1853-1864(2007). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE NUP107-160 RP COMPLEX. RX PubMed=17360435; DOI=10.1073/pnas.0700058104; RA Glavy J.S., Krutchinsky A.N., Cristea I.M., Berke I.C., Boehmer T., RA Blobel G., Chait B.T.; RT "Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 RT subcomplex."; RL Proc. Natl. Acad. Sci. U.S.A. 104:3811-3816(2007). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [10] RP ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). CC -!- FUNCTION: Component of the Nup107-160 subcomplex of the nuclear pore CC complex (NPC). The Nup107-160 subcomplex is required for the assembly CC of a functional NPC. The Nup107-160 subcomplex is also required for CC normal kinetochore microtubule attachment, mitotic progression and CC chromosome segregation. {ECO:0000269|PubMed:17363900}. CC -!- SUBUNIT: Component of the Nup107-160 subcomplex of the nuclear pore CC complex (NPC). The Nup107-160 subcomplex includes NUP160, NUP133, CC NUP107, NUP98, NUP85, NUP43, NUP37, SEH1 and SEC13. CC {ECO:0000269|PubMed:15146057, ECO:0000269|PubMed:17360435}. CC -!- INTERACTION: CC Q8NFH3; P54253: ATXN1; NbExp=6; IntAct=EBI-1059321, EBI-930964; CC Q8NFH3; P54252: ATXN3; NbExp=3; IntAct=EBI-1059321, EBI-946046; CC Q8NFH3; P55212: CASP6; NbExp=3; IntAct=EBI-1059321, EBI-718729; CC Q8NFH3; P06307: CCK; NbExp=3; IntAct=EBI-1059321, EBI-6624398; CC Q8NFH3; P07686: HEXB; NbExp=3; IntAct=EBI-1059321, EBI-7133736; CC Q8NFH3; P13473-2: LAMP2; NbExp=3; IntAct=EBI-1059321, EBI-21591415; CC Q8NFH3; Q99497: PARK7; NbExp=3; IntAct=EBI-1059321, EBI-1164361; CC Q8NFH3; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-1059321, EBI-5280197; CC Q8NFH3; Q13148: TARDBP; NbExp=3; IntAct=EBI-1059321, EBI-372899; CC Q8NFH3; P02766: TTR; NbExp=3; IntAct=EBI-1059321, EBI-711909; CC -!- SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore. Nucleus, CC nuclear pore complex. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8NFH3-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8NFH3-2; Sequence=VSP_056167; CC -!- SEQUENCE CAUTION: CC Sequence=BAB14536.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF514997; AAM76708.1; -; mRNA. DR EMBL; AK023349; BAB14536.1; ALT_INIT; mRNA. DR EMBL; AK304244; BAG65112.1; -; mRNA. DR EMBL; AL355312; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC065028; AAH65028.1; -; mRNA. DR CCDS; CCDS5218.1; -. [Q8NFH3-1] DR RefSeq; NP_942590.1; NM_198887.2. [Q8NFH3-1] DR PDB; 4I79; X-ray; 1.75 A; A/B=1-380. DR PDB; 5A9Q; EM; 23.00 A; 0/9/I/R=1-380. DR PDB; 7PEQ; EM; 35.00 A; AI/BI/CI/DI=1-380. DR PDB; 7R5J; EM; 50.00 A; Q0/Q1/Q2/Q3=1-380. DR PDB; 7R5K; EM; 12.00 A; Q0/Q1/Q2/Q3=1-380. DR PDBsum; 4I79; -. DR PDBsum; 5A9Q; -. DR PDBsum; 7PEQ; -. DR PDBsum; 7R5J; -. DR PDBsum; 7R5K; -. DR AlphaFoldDB; Q8NFH3; -. DR EMDB; EMD-14321; -. DR EMDB; EMD-14322; -. DR SMR; Q8NFH3; -. DR BioGRID; 131544; 627. DR ComplexPortal; CPX-873; Nuclear pore complex. DR CORUM; Q8NFH3; -. DR IntAct; Q8NFH3; 48. DR MINT; Q8NFH3; -. DR STRING; 9606.ENSP00000342262; -. DR TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family. DR GlyGen; Q8NFH3; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q8NFH3; -. DR PhosphoSitePlus; Q8NFH3; -. DR SwissPalm; Q8NFH3; -. DR BioMuta; NUP43; -. DR DMDM; 27923819; -. DR EPD; Q8NFH3; -. DR jPOST; Q8NFH3; -. DR MassIVE; Q8NFH3; -. DR MaxQB; Q8NFH3; -. DR PaxDb; 9606-ENSP00000342262; -. DR PeptideAtlas; Q8NFH3; -. DR ProteomicsDB; 5814; -. DR ProteomicsDB; 73305; -. [Q8NFH3-1] DR Pumba; Q8NFH3; -. DR Antibodypedia; 33283; 300 antibodies from 23 providers. DR DNASU; 348995; -. DR Ensembl; ENST00000340413.7; ENSP00000342262.2; ENSG00000120253.14. [Q8NFH3-1] DR Ensembl; ENST00000367404.8; ENSP00000356374.4; ENSG00000120253.14. [Q8NFH3-2] DR GeneID; 348995; -. DR KEGG; hsa:348995; -. DR MANE-Select; ENST00000340413.7; ENSP00000342262.2; NM_198887.3; NP_942590.1. DR UCSC; uc003qmz.5; human. [Q8NFH3-1] DR AGR; HGNC:21182; -. DR CTD; 348995; -. DR DisGeNET; 348995; -. DR GeneCards; NUP43; -. DR HGNC; HGNC:21182; NUP43. DR HPA; ENSG00000120253; Low tissue specificity. DR MIM; 608141; gene. DR neXtProt; NX_Q8NFH3; -. DR OpenTargets; ENSG00000120253; -. DR PharmGKB; PA134930788; -. DR VEuPathDB; HostDB:ENSG00000120253; -. DR eggNOG; KOG4714; Eukaryota. DR GeneTree; ENSGT00390000004803; -. DR HOGENOM; CLU_060663_1_0_1; -. DR InParanoid; Q8NFH3; -. DR OMA; HDGDVMD; -. DR OrthoDB; 119005at2759; -. DR PhylomeDB; Q8NFH3; -. DR TreeFam; TF321692; -. DR PathwayCommons; Q8NFH3; -. DR Reactome; R-HSA-1169408; ISG15 antiviral mechanism. DR Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal. DR Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA. DR Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA. DR Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript. DR Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript. DR Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA. DR Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus. DR Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways. DR Reactome; R-HSA-168325; Viral Messenger RNA Synthesis. DR Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery. DR Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein. DR Reactome; R-HSA-180746; Nuclear import of Rev protein. DR Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs. DR Reactome; R-HSA-191859; snRNP Assembly. DR Reactome; R-HSA-2467813; Separation of Sister Chromatids. DR Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion. DR Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins. DR Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins. DR Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly. DR Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response. DR Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins. DR Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins. DR Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins. DR Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins. DR Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs. DR Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC). DR Reactome; R-HSA-5663220; RHO GTPases Activate Formins. DR Reactome; R-HSA-6784531; tRNA processing in the nucleus. DR Reactome; R-HSA-68877; Mitotic Prometaphase. DR Reactome; R-HSA-9609690; HCMV Early Events. DR Reactome; R-HSA-9610379; HCMV Late Events. DR Reactome; R-HSA-9615933; Postmitotic nuclear pore complex (NPC) reformation. DR Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation. DR Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses. DR SignaLink; Q8NFH3; -. DR SIGNOR; Q8NFH3; -. DR BioGRID-ORCS; 348995; 683 hits in 1182 CRISPR screens. DR ChiTaRS; NUP43; human. DR GeneWiki; NUP43; -. DR GenomeRNAi; 348995; -. DR Pharos; Q8NFH3; Tbio. DR PRO; PR:Q8NFH3; -. DR Proteomes; UP000005640; Chromosome 6. DR RNAct; Q8NFH3; Protein. DR Bgee; ENSG00000120253; Expressed in oocyte and 207 other cell types or tissues. DR ExpressionAtlas; Q8NFH3; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0000776; C:kinetochore; IEA:UniProtKB-KW. DR GO; GO:0005635; C:nuclear envelope; IDA:ComplexPortal. DR GO; GO:0005643; C:nuclear pore; NAS:ComplexPortal. DR GO; GO:0031080; C:nuclear pore outer ring; IDA:UniProtKB. DR GO; GO:0016607; C:nuclear speck; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW. DR GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW. DR GO; GO:0006913; P:nucleocytoplasmic transport; NAS:ComplexPortal. DR GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW. DR Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR019775; WD40_repeat_CS. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR InterPro; IPR001680; WD40_rpt. DR PANTHER; PTHR22652; NUCLEOPORIN NUP43; 1. DR PANTHER; PTHR22652:SF0; NUCLEOPORIN NUP43; 1. DR Pfam; PF00400; WD40; 2. DR SMART; SM00320; WD40; 5. DR SUPFAM; SSF50978; WD40 repeat-like; 1. DR PROSITE; PS00678; WD_REPEATS_1; 1. DR PROSITE; PS50082; WD_REPEATS_2; 2. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. DR Genevisible; Q8NFH3; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; Cell cycle; Cell division; KW Centromere; Chromosome; Chromosome partition; Kinetochore; Mitosis; KW mRNA transport; Nuclear pore complex; Nucleus; Protein transport; KW Reference proteome; Repeat; Translocation; Transport; WD repeat. FT CHAIN 1..380 FT /note="Nucleoporin Nup43" FT /id="PRO_0000051111" FT REPEAT 8..57 FT /note="WD 1" FT REPEAT 72..110 FT /note="WD 2" FT REPEAT 127..166 FT /note="WD 3" FT REPEAT 170..208 FT /note="WD 4" FT REPEAT 215..255 FT /note="WD 5" FT REPEAT 259..299 FT /note="WD 6" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0007744|PubMed:22814378" FT VAR_SEQ 168..264 FT /note="DNADSSTLHAVTFLRTPEILTVNSIGQLKIWDFRQQGNEPSQILSLTGDRVP FT LHCVDRHPNQQHVVATGGQDGMLSIWDVRQGTMPVSLLKAHEAEM -> V (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_056167" FT CONFLICT 247 FT /note="V -> A (in Ref. 2; BAB14536)" FT /evidence="ECO:0000305" FT STRAND 5..8 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 10..18 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 31..48 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 66..75 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 77..92 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 97..102 FT /evidence="ECO:0007829|PDB:4I79" FT TURN 104..106 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 109..115 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 118..120 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 134..140 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 143..148 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 151..157 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 164..168 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 175..182 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 185..190 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 193..199 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 203..205 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 208..212 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 214..217 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 220..225 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 232..237 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 242..246 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 254..257 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 264..269 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 276..281 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 286..290 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 341..344 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 353..359 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 362..367 FT /evidence="ECO:0007829|PDB:4I79" FT STRAND 370..376 FT /evidence="ECO:0007829|PDB:4I79" SQ SEQUENCE 380 AA; 42151 MW; EE44714B8E5BFB42 CRC64; MEEIYAKFVS QKISKTRWRP LPPGSLQTAE TFATGSWDNE ENYISLWSIG DFGNLDSDGG FEGDHQLLCD IRHHGDVMDL QFFDQERIVA ASSTGCVTVF LHHPNNQTLS VNQQWTTAHY HTGPGSPSYS SAPCTGVVCN NPEIVTVGED GRINLFRADH KEAVRTIDNA DSSTLHAVTF LRTPEILTVN SIGQLKIWDF RQQGNEPSQI LSLTGDRVPL HCVDRHPNQQ HVVATGGQDG MLSIWDVRQG TMPVSLLKAH EAEMWEVHFH PSNPEHLFTC SEDGSLWHWD ASTDVPEKSS LFHQGGRSST FLSHSISNQA NVHQSVISSW LSTDPAKDRI EITSLLPSRS LSVNTLDVLG PCLVCGTDAE AIYVTRHLFS //